Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Cash Flow Reinvestment Rate
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow Reinvestment Rate of 0.46x as of September 2025, reinvesting CN¥32.02 Million (capex CN¥32.02 Million ) from operating cash flow of CN¥69.15 Million. Check Anhui Fengyuan Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Anhui Fengyuan Pharmaceutical Co Ltd across 24 annual periods. Explore Anhui Fengyuan Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Anhui Fengyuan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Anhui Fengyuan Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.27x | CN¥270.65 Million | CN¥119.30 Million | CN¥220.61 Million | ▲ +13.7% |
| 2024 | 2.00x | CN¥251.93 Million | CN¥126.24 Million | CN¥144.02 Million | ▲ +222.8% |
| 2023 | 0.62x | CN¥157.48 Million | CN¥254.75 Million | CN¥152.12 Million | ▲ +150.1% |
| 2022 | 0.25x | CN¥108.76 Million | CN¥439.99 Million | CN¥81.76 Million | ▼ -64.2% |
| 2021 | 0.69x | CN¥164.26 Million | CN¥237.88 Million | CN¥157.36 Million | ▼ -25.2% |
| 2020 | 0.92x | CN¥270.07 Million | CN¥292.75 Million | CN¥190.74 Million | ▼ -83.3% |
| 2019 | 5.54x | CN¥366.62 Million | CN¥66.21 Million | CN¥145.62 Million | ▲ +600.4% |
| 2018 | 0.79x | CN¥184.65 Million | CN¥233.59 Million | CN¥84.63 Million | ▼ -21.3% |
| 2017 | 1.00x | CN¥52.60 Million | CN¥52.40 Million | CN¥47.99 Million | ▲ +70.2% |
| 2016 | 0.59x | CN¥46.15 Million | CN¥78.21 Million | CN¥22.17 Million | ▼ -47.8% |
| 2015 | 1.13x | CN¥51.43 Million | CN¥45.50 Million | CN¥50.33 Million | ▼ -93.2% |
| 2014 | 16.73x | CN¥175.86 Million | CN¥10.51 Million | CN¥175.86 Million | ▲ +703.5% |
| 2012 | 2.08x | CN¥95.06 Million | CN¥45.65 Million | CN¥95.06 Million | ▲ +64.1% |
| 2011 | 1.27x | CN¥69.86 Million | CN¥55.06 Million | CN¥69.86 Million | ▼ -22.2% |
| 2010 | 1.63x | CN¥89.75 Million | CN¥55.04 Million | CN¥89.75 Million | ▼ -29.0% |
| 2009 | 2.30x | CN¥74.42 Million | CN¥32.41 Million | CN¥74.42 Million | ▲ +262.3% |
| 2008 | 0.63x | CN¥31.58 Million | CN¥49.82 Million | CN¥31.58 Million | ▼ -0.4% |
| 2007 | 0.64x | CN¥35.18 Million | CN¥55.26 Million | CN¥35.18 Million | ▼ -83.1% |
| 2006 | 3.77x | CN¥136.67 Million | CN¥36.27 Million | CN¥136.67 Million | ▲ +268.4% |
| 2005 | 1.02x | CN¥35.68 Million | CN¥34.88 Million | CN¥35.68 Million | ▼ -88.3% |
| 2002 | 8.73x | CN¥91.40 Million | CN¥10.48 Million | CN¥91.40 Million | ▲ +8.1% |
| 2001 | 8.07x | CN¥190.24 Million | CN¥23.57 Million | CN¥190.24 Million | ▲ +77.3% |
| 2000 | 4.55x | CN¥117.82 Million | CN¥25.88 Million | CN¥117.82 Million | ▲ +0.5% |
| 1999 | 4.53x | CN¥4.59 Million | CN¥1.01 Million | CN¥4.59 Million | — |